1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-Parkinson Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Dopaminergic
        1.2.3 Dopamine Agonists
        1.2.4 Enzyme Inhibitors
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Anti-Parkinson Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Stores
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Anti-Parkinson Drugs Market Perspective (2017-2028)
    2.2 Anti-Parkinson Drugs Growth Trends by Region
        2.2.1 Anti-Parkinson Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Anti-Parkinson Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Anti-Parkinson Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Anti-Parkinson Drugs Market Dynamics
        2.3.1 Anti-Parkinson Drugs Industry Trends
        2.3.2 Anti-Parkinson Drugs Market Drivers
        2.3.3 Anti-Parkinson Drugs Market Challenges
        2.3.4 Anti-Parkinson Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Anti-Parkinson Drugs Players by Revenue
        3.1.1 Global Top Anti-Parkinson Drugs Players by Revenue (2017-2022)
        3.1.2 Global Anti-Parkinson Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Anti-Parkinson Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Anti-Parkinson Drugs Revenue
    3.4 Global Anti-Parkinson Drugs Market Concentration Ratio
        3.4.1 Global Anti-Parkinson Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-Parkinson Drugs Revenue in 2021
    3.5 Anti-Parkinson Drugs Key Players Head office and Area Served
    3.6 Key Players Anti-Parkinson Drugs Product Solution and Service
    3.7 Date of Enter into Anti-Parkinson Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Parkinson Drugs Breakdown Data by Type
    4.1 Global Anti-Parkinson Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Anti-Parkinson Drugs Forecasted Market Size by Type (2023-2028)
5 Anti-Parkinson Drugs Breakdown Data by Application
    5.1 Global Anti-Parkinson Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Anti-Parkinson Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Anti-Parkinson Drugs Market Size (2017-2028)
    6.2 North America Anti-Parkinson Drugs Market Size by Type
        6.2.1 North America Anti-Parkinson Drugs Market Size by Type (2017-2022)
        6.2.2 North America Anti-Parkinson Drugs Market Size by Type (2023-2028)
        6.2.3 North America Anti-Parkinson Drugs Market Share by Type (2017-2028)
    6.3 North America Anti-Parkinson Drugs Market Size by Application
        6.3.1 North America Anti-Parkinson Drugs Market Size by Application (2017-2022)
        6.3.2 North America Anti-Parkinson Drugs Market Size by Application (2023-2028)
        6.3.3 North America Anti-Parkinson Drugs Market Share by Application (2017-2028)
    6.4 North America Anti-Parkinson Drugs Market Size by Country
        6.4.1 North America Anti-Parkinson Drugs Market Size by Country (2017-2022)
        6.4.2 North America Anti-Parkinson Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Anti-Parkinson Drugs Market Size (2017-2028)
    7.2 Europe Anti-Parkinson Drugs Market Size by Type
        7.2.1 Europe Anti-Parkinson Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Anti-Parkinson Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Anti-Parkinson Drugs Market Share by Type (2017-2028)
    7.3 Europe Anti-Parkinson Drugs Market Size by Application
        7.3.1 Europe Anti-Parkinson Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Anti-Parkinson Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Anti-Parkinson Drugs Market Share by Application (2017-2028)
    7.4 Europe Anti-Parkinson Drugs Market Size by Country
        7.4.1 Europe Anti-Parkinson Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Anti-Parkinson Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Anti-Parkinson Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Type
        8.2.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Anti-Parkinson Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Application
        8.3.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Anti-Parkinson Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Anti-Parkinson Drugs Market Size by Region
        8.4.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Anti-Parkinson Drugs Market Size (2017-2028)
    9.2 Latin America Anti-Parkinson Drugs Market Size by Type
        9.2.1 Latin America Anti-Parkinson Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Anti-Parkinson Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Anti-Parkinson Drugs Market Share by Type (2017-2028)
    9.3 Latin America Anti-Parkinson Drugs Market Size by Application
        9.3.1 Latin America Anti-Parkinson Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Anti-Parkinson Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Anti-Parkinson Drugs Market Share by Application (2017-2028)
    9.4 Latin America Anti-Parkinson Drugs Market Size by Country
        9.4.1 Latin America Anti-Parkinson Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Anti-Parkinson Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Anti-Parkinson Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type
        10.2.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Anti-Parkinson Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Application
        10.3.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Anti-Parkinson Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Anti-Parkinson Drugs Market Size by Country
        10.4.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Anti-Parkinson Drugs Introduction
        11.1.4 AbbVie Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.1.5 AbbVie Recent Developments
    11.2 Mylan Laboratories
        11.2.1 Mylan Laboratories Company Details
        11.2.2 Mylan Laboratories Business Overview
        11.2.3 Mylan Laboratories Anti-Parkinson Drugs Introduction
        11.2.4 Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.2.5 Mylan Laboratories Recent Developments
    11.3 Valeant Pharmaceuticals
        11.3.1 Valeant Pharmaceuticals Company Details
        11.3.2 Valeant Pharmaceuticals Business Overview
        11.3.3 Valeant Pharmaceuticals Anti-Parkinson Drugs Introduction
        11.3.4 Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.3.5 Valeant Pharmaceuticals Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Anti-Parkinson Drugs Introduction
        11.4.4 Novartis Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Details
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Anti-Parkinson Drugs Introduction
        11.5.4 GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Developments
    11.6 Zambon Pharmaceuticals
        11.6.1 Zambon Pharmaceuticals Company Details
        11.6.2 Zambon Pharmaceuticals Business Overview
        11.6.3 Zambon Pharmaceuticals Anti-Parkinson Drugs Introduction
        11.6.4 Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.6.5 Zambon Pharmaceuticals Recent Developments
    11.7 Pfizer, Inc.
        11.7.1 Pfizer, Inc. Company Details
        11.7.2 Pfizer, Inc. Business Overview
        11.7.3 Pfizer, Inc. Anti-Parkinson Drugs Introduction
        11.7.4 Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.7.5 Pfizer, Inc. Recent Developments
    11.8 Hoffmann-La Roche
        11.8.1 Hoffmann-La Roche Company Details
        11.8.2 Hoffmann-La Roche Business Overview
        11.8.3 Hoffmann-La Roche Anti-Parkinson Drugs Introduction
        11.8.4 Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.8.5 Hoffmann-La Roche Recent Developments
    11.9 Merck & Co.
        11.9.1 Merck & Co. Company Details
        11.9.2 Merck & Co. Business Overview
        11.9.3 Merck & Co. Anti-Parkinson Drugs Introduction
        11.9.4 Merck & Co. Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.9.5 Merck & Co. Recent Developments
    11.10 Orion Pharma
        11.10.1 Orion Pharma Company Details
        11.10.2 Orion Pharma Business Overview
        11.10.3 Orion Pharma Anti-Parkinson Drugs Introduction
        11.10.4 Orion Pharma Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.10.5 Orion Pharma Recent Developments
    11.11 UCB
        11.11.1 UCB Company Details
        11.11.2 UCB Business Overview
        11.11.3 UCB Anti-Parkinson Drugs Introduction
        11.11.4 UCB Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.11.5 UCB Recent Developments
    11.12 Teva Pharmaceutical Industries Ltd.
        11.12.1 Teva Pharmaceutical Industries Ltd. Company Details
        11.12.2 Teva Pharmaceutical Industries Ltd. Business Overview
        11.12.3 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Introduction
        11.12.4 Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.12.5 Teva Pharmaceutical Industries Ltd. Recent Developments
    11.13 Vertical Pharmaceuticals, LLC
        11.13.1 Vertical Pharmaceuticals, LLC Company Details
        11.13.2 Vertical Pharmaceuticals, LLC Business Overview
        11.13.3 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Introduction
        11.13.4 Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.13.5 Vertical Pharmaceuticals, LLC Recent Developments
    11.14 ACADIA Pharmaceuticals Inc.
        11.14.1 ACADIA Pharmaceuticals Inc. Company Details
        11.14.2 ACADIA Pharmaceuticals Inc. Business Overview
        11.14.3 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Introduction
        11.14.4 ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2017-2022)
        11.14.5 ACADIA Pharmaceuticals Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Anti-Parkinson Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Dopaminergic
    Table 3. Key Players of Dopamine Agonists
    Table 4. Key Players of Enzyme Inhibitors
    Table 5. Key Players of Others
    Table 6. Global Anti-Parkinson Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Anti-Parkinson Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Anti-Parkinson Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Anti-Parkinson Drugs Market Share by Region (2017-2022)
    Table 10. Global Anti-Parkinson Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Anti-Parkinson Drugs Market Share by Region (2023-2028)
    Table 12. Anti-Parkinson Drugs Market Trends
    Table 13. Anti-Parkinson Drugs Market Drivers
    Table 14. Anti-Parkinson Drugs Market Challenges
    Table 15. Anti-Parkinson Drugs Market Restraints
    Table 16. Global Anti-Parkinson Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Anti-Parkinson Drugs Revenue Share by Players (2017-2022)
    Table 18. Global Top Anti-Parkinson Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Parkinson Drugs as of 2021)
    Table 19. Ranking of Global Top Anti-Parkinson Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Anti-Parkinson Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Anti-Parkinson Drugs Product Solution and Service
    Table 23. Date of Enter into Anti-Parkinson Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anti-Parkinson Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Anti-Parkinson Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global Anti-Parkinson Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Anti-Parkinson Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global Anti-Parkinson Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Anti-Parkinson Drugs Revenue Share by Application (2017-2022)
    Table 31. Global Anti-Parkinson Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Anti-Parkinson Drugs Revenue Share by Application (2023-2028)
    Table 33. North America Anti-Parkinson Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Anti-Parkinson Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Anti-Parkinson Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Anti-Parkinson Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Anti-Parkinson Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Anti-Parkinson Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Anti-Parkinson Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Anti-Parkinson Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Anti-Parkinson Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Anti-Parkinson Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Anti-Parkinson Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Anti-Parkinson Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Anti-Parkinson Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Anti-Parkinson Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Anti-Parkinson Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Anti-Parkinson Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Anti-Parkinson Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Anti-Parkinson Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Anti-Parkinson Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Anti-Parkinson Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Anti-Parkinson Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Anti-Parkinson Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Anti-Parkinson Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Anti-Parkinson Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Anti-Parkinson Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Anti-Parkinson Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Anti-Parkinson Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Anti-Parkinson Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Anti-Parkinson Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Anti-Parkinson Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 63. AbbVie Company Details
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Anti-Parkinson Drugs Product
    Table 66. AbbVie Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 67. AbbVie Recent Developments
    Table 68. Mylan Laboratories Company Details
    Table 69. Mylan Laboratories Business Overview
    Table 70. Mylan Laboratories Anti-Parkinson Drugs Product
    Table 71. Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 72. Mylan Laboratories Recent Developments
    Table 73. Valeant Pharmaceuticals Company Details
    Table 74. Valeant Pharmaceuticals Business Overview
    Table 75. Valeant Pharmaceuticals Anti-Parkinson Drugs Product
    Table 76. Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 77. Valeant Pharmaceuticals Recent Developments
    Table 78. Novartis Company Details
    Table 79. Novartis Business Overview
    Table 80. Novartis Anti-Parkinson Drugs Product
    Table 81. Novartis Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Developments
    Table 83. GlaxoSmithKline Company Details
    Table 84. GlaxoSmithKline Business Overview
    Table 85. GlaxoSmithKline Anti-Parkinson Drugs Product
    Table 86. GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 87. GlaxoSmithKline Recent Developments
    Table 88. Zambon Pharmaceuticals Company Details
    Table 89. Zambon Pharmaceuticals Business Overview
    Table 90. Zambon Pharmaceuticals Anti-Parkinson Drugs Product
    Table 91. Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 92. Zambon Pharmaceuticals Recent Developments
    Table 93. Pfizer, Inc. Company Details
    Table 94. Pfizer, Inc. Business Overview
    Table 95. Pfizer, Inc. Anti-Parkinson Drugs Product
    Table 96. Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 97. Pfizer, Inc. Recent Developments
    Table 98. Hoffmann-La Roche Company Details
    Table 99. Hoffmann-La Roche Business Overview
    Table 100. Hoffmann-La Roche Anti-Parkinson Drugs Product
    Table 101. Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 102. Hoffmann-La Roche Recent Developments
    Table 103. Merck & Co. Company Details
    Table 104. Merck & Co. Business Overview
    Table 105. Merck & Co. Anti-Parkinson Drugs Product
    Table 106. Merck & Co. Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 107. Merck & Co. Recent Developments
    Table 108. Orion Pharma Company Details
    Table 109. Orion Pharma Business Overview
    Table 110. Orion Pharma Anti-Parkinson Drugs Product
    Table 111. Orion Pharma Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 112. Orion Pharma Recent Developments
    Table 113. UCB Company Details
    Table 114. UCB Business Overview
    Table 115. UCB Anti-Parkinson Drugs Product
    Table 116. UCB Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 117. UCB Recent Developments
    Table 118. Teva Pharmaceutical Industries Ltd. Company Details
    Table 119. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 120. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product
    Table 121. Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 122. Teva Pharmaceutical Industries Ltd. Recent Developments
    Table 123. Vertical Pharmaceuticals, LLC Company Details
    Table 124. Vertical Pharmaceuticals, LLC Business Overview
    Table 125. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product
    Table 126. Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 127. Vertical Pharmaceuticals, LLC Recent Developments
    Table 128. ACADIA Pharmaceuticals Inc. Company Details
    Table 129. ACADIA Pharmaceuticals Inc. Business Overview
    Table 130. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product
    Table 131. ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2017-2022) & (US$ Million)
    Table 132. ACADIA Pharmaceuticals Inc. Recent Developments
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-Parkinson Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Dopaminergic Features
    Figure 3. Dopamine Agonists Features
    Figure 4. Enzyme Inhibitors Features
    Figure 5. Others Features
    Figure 6. Global Anti-Parkinson Drugs Market Share by Application: 2021 VS 2028
    Figure 7. Hospital Pharmacy Case Studies
    Figure 8. Retail Pharmacy Case Studies
    Figure 9. Online Stores Case Studies
    Figure 10. Anti-Parkinson Drugs Report Years Considered
    Figure 11. Global Anti-Parkinson Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Anti-Parkinson Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Anti-Parkinson Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Anti-Parkinson Drugs Market Share by Players in 2021
    Figure 15. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Parkinson Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2021
    Figure 17. North America Anti-Parkinson Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Anti-Parkinson Drugs Market Size Market Share by Type (2017-2028)
    Figure 19. North America Anti-Parkinson Drugs Market Size Market Share by Application (2017-2028)
    Figure 20. North America Anti-Parkinson Drugs Market Size Share by Country (2017-2028)
    Figure 21. United States Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Anti-Parkinson Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Anti-Parkinson Drugs Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Anti-Parkinson Drugs Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Anti-Parkinson Drugs Market Size Share by Country (2017-2028)
    Figure 27. Germany Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Anti-Parkinson Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Anti-Parkinson Drugs Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Anti-Parkinson Drugs Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Anti-Parkinson Drugs Market Size Share by Region (2017-2028)
    Figure 37. China Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Anti-Parkinson Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Anti-Parkinson Drugs Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Anti-Parkinson Drugs Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Anti-Parkinson Drugs Market Size Share by Country (2017-2028)
    Figure 47. Mexico Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Anti-Parkinson Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Anti-Parkinson Drugs Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Anti-Parkinson Drugs Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Anti-Parkinson Drugs Market Size Share by Country (2017-2028)
    Figure 53. Turkey Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Anti-Parkinson Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. AbbVie Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 57. Mylan Laboratories Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 58. Valeant Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 60. GlaxoSmithKline Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 61. Zambon Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 62. Pfizer, Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 63. Hoffmann-La Roche Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 64. Merck & Co. Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 65. Orion Pharma Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 66. UCB Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 67. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 68. Vertical Pharmaceuticals, LLC Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 69. ACADIA Pharmaceuticals Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed